Published online Jun 21, 2014. doi: 10.3748/wjg.v20.i23.7523
Revised: January 12, 2014
Accepted: March 4, 2014
Published online: June 21, 2014
Processing time: 255 Days and 21.7 Hours
Hepatic venous pressure gradient (HVPG) is an independent predictor of variceal rebleeding in patients with cirrhosis. After pharmacological and/or endoscopic therapy, the use of a transjugular intrahepatic portosystemic shunt (TIPS) may be necessary in HVPG non-responders, but not in responders. Thus, HVPG measurement may be incorporated into the treatment algorithm for acute variceal bleeding, which further identifies the candidates that should undergo early insertion of TIPS or maintain the traditional pharmacological and/or endoscopic therapy. The potential benefits are to reduce the cost and prevent TIPS-related complications.
Core tip: If hepatic venous pressure gradient could be measured before a transjugular intrahepatic portosystemic shunt for the treatment of acute variceal bleeding, the invasiveness of treatment strategy would be further decreased.